Literature DB >> 1929679

Atherogenic effects of anabolic steroids on serum lipid levels. A literature review.

G Glazer1.   

Abstract

This article reviews the current body of literature linking anabolic steroids to atherogenic alterations in serum lipid levels. Anabolic steroids cause marked high-density lipoprotein2 levels [corrected] depression (weighted average, 52%) and severe depression of high-density lipoprotein b levels (weighted average, 78%) while raising low-density lipoprotein levels an average of 36%. The mechanism of these lipid changes, their time course in relation to anabolic steroid use, and their dependency on route of anabolic steroid administration are discussed. Interpretation of the observed lipid level changes in light of the epidemiologic data linking lipids to coronary heart disease risk is used to estimate the lipid-based increase in coronary heart disease risk due to anabolic steroid use.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1929679

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  32 in total

1.  Relationship between testosterone and erectile dysfunction.

Authors:  J Rajfer
Journal:  Rev Urol       Date:  2000

2.  Adverse effect of the anabolic-androgenic steroid mesterolone on cardiac remodelling and lipoprotein profile is attenuated by aerobicz exercise training.

Authors:  Karina Fontana; Helena Coutinho Franco Oliveira; Marta Beatriz Leonardo; Carlos Alberto Mandarim-de-Lacerda; Maria Alice da Cruz-Höfling
Journal:  Int J Exp Pathol       Date:  2008-10       Impact factor: 1.925

Review 3.  The paradox of low BNP levels in obesity.

Authors:  Aldo Clerico; Alberto Giannoni; Simona Vittorini; Michele Emdin
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

Review 4.  [Sports cardiology : Overview of relevant clinical topics].

Authors:  R Laszlo; J Scharhag; C Burgstahler; H Striegel; J M Steinacker
Journal:  Herz       Date:  2017-01-23       Impact factor: 1.443

5.  Response to androgen therapy in patients with dyskeratosis congenita.

Authors:  Payal P Khincha; Ingrid M Wentzensen; Neelam Giri; Blanche P Alter; Sharon A Savage
Journal:  Br J Haematol       Date:  2014-02-12       Impact factor: 6.998

Review 6.  Cardiac and metabolic effects of anabolic-androgenic steroid abuse on lipids, blood pressure, left ventricular dimensions, and rhythm.

Authors:  Suraj Achar; Armand Rostamian; Sanjiv M Narayan
Journal:  Am J Cardiol       Date:  2010-09-15       Impact factor: 2.778

Review 7.  Effects of androgenic-anabolic steroids in athletes.

Authors:  Fred Hartgens; Harm Kuipers
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 8.  Illicit anabolic-androgenic steroid use.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Horm Behav       Date:  2009-09-18       Impact factor: 3.587

Review 9.  Approach to the patient with extremely low HDL-cholesterol.

Authors:  Daniel J Rader; Emil M deGoma
Journal:  J Clin Endocrinol Metab       Date:  2012-10       Impact factor: 5.958

10.  Homocysteine induced cardiovascular events: a consequence of long term anabolic-androgenic steroid (AAS) abuse.

Authors:  M R Graham; F M Grace; W Boobier; D Hullin; A Kicman; D Cowan; B Davies; J S Baker
Journal:  Br J Sports Med       Date:  2006-02-17       Impact factor: 13.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.